Dolby Laboratories, Inc.
DLB
$54.06
-$0.06-0.11%
NYSE
| 03/27/2026 | 12/26/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.11% | 12.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.11% | 12.92% | |||
| Cost of Revenue | 3.52% | 9.33% | |||
| Gross Profit | 15.62% | 13.46% | |||
| SG&A Expenses | 6.38% | -1.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.34% | 1.05% | |||
| Operating Income | 58.52% | 102.84% | |||
| Income Before Tax | 67.17% | 71.84% | |||
| Income Tax Expenses | 35.29% | 324.41% | |||
| Earnings from Continuing Operations | 77.82% | 8.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -52.26% | -9.94% | |||
| Net Income | 77.99% | 8.10% | |||
| EBIT | 58.52% | 102.84% | |||
| EBITDA | 43.87% | 67.42% | |||
| EPS Basic | 78.45% | 8.28% | |||
| Normalized Basic EPS | 48.33% | 72.69% | |||
| EPS Diluted | 80.00% | 7.40% | |||
| Normalized Diluted EPS | 49.51% | 72.99% | |||
| Average Basic Shares Outstanding | -0.26% | -0.17% | |||
| Average Diluted Shares Outstanding | -1.04% | -0.34% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.44% | 0.01% | |||